MJ

Manish Jain

Chief Technology Officer

Thymmune Therapeutics

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Thymmune Therapeutics
Industry
biotechnology
Employees
27.0
Seniority
C suite
Annual Revenue
1200000.0
Total Funding
44000000.0
Latest Funding
Other

Technologies

Gmail Google Apps Microsoft Office 365 Zendesk Typekit Mobile Friendly YouTube Squarespace ECommerce Remote

Keywords

thymic cell engineering immune function restoration machine learning ipsc manufacturing off-the-shelf cells immune therapies immunodeficiencies treatment autoimmune disorders t cell development thymus gland aging therapies cell therapy preclinical studies human-induced pluripotent stem cells thymus rejuvenation transplant-related therapies immune decline biopharmaceuticals therapeutic pipeline immune system disorders stem cell innovation thymic epithelial cells scalable cell production healthier aging fda-approved methods thymic regeneration thymic health biotech funding stem cell startup invasive alternatives biomedical research clinical drug development immunology advances biotechnological solutions affordable therapies immunology pioneer immune rejuvenating therapies thymic dysfunction practical treatments innovative health solutions biomedical innovation precision medicine next-generation therapies t cell maturation advanced research biotech collaboration artificial intelligence information technology & services

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans